References
- Strong M. J., Kesavapany S., Pant H. C. The pathobiology of amyotrophic lateral sclerosis: a proteinopathy?. J Neuropathol Exp Neurol 2005; 64: 649–64
- Stern B. Neurological complications of sarcoidosis. Curr Opin Neurol 2004; 17: 311–6
- Weydt P., Yuen E., Ransom B., Moller T. Increased cytotoxic potential of microglia from ALS transgenic mice. Glia 2004; 48: 179–82
- Poloni M., Facchetti D., Mai R., Micheli A., Agnoletti L., Francolini G., et al. Circulating levels of tumor necrosis factor‐alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci Lett 2000; 287: 211–4
- Henkel J. S., Engelhardt J. I., Siklos L., Simpson E. P., Kim S. H., Pan T., et al. Presence of dendritic cells, MCP‐1 and activated microlia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 2004; 55: 221–35
- Martin W., Iannuzzi M., Gail D., Peavy H. Future directions in sarcoidosis research. Am J Resp Crit Med 2004; 170: 567–71
- Koide T., Kanazawa M., Shinbo J., Urayama K., Yagi N., Tsuchida S., et al. A patient with sarcoidosis needed differential diagnosis from motor neuron disease. Rinsho Shinkeigaku 2005; 45: 485–9
- Saiki S., Yoshioka A., Yamaya Y., Hirose G. Amyotrophic lateral sclerosis associated with sarcoidosis. Intern Med 2001; 40: 822–5